NOTICE OF ALLOWANCE - ISSUED
issued
on 04 Jun 2024
Last Applicant/ Owned by
451 D Street
Boston
MA
02210
Serial Number
97822253 filed on 03rd Mar 2023
Registration Number
N/A
Correspondent Address
Christina M. Licursi
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
D DEWPOINT THERAPEUTICS
Scientific research in the field of genetics, gene therapy and genetic engineering; genetic testing for scientific research purposes; Scientific, biological, pharmaceutical and medical research services; Laboratory research in the fields of genetics, drug development, biotechnology, microbiology and molecular biology; Pharmaceutical drug discovery and drug development services; Biological research Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Scientific research in the field of genetics, gene therapy and genetic engineering; genetic testing for scientific research purposes; Scientific, biological, pharmaceutical and medical research services; Laboratory research in the fields of genetics, drug development, biotechnology, microbiology and molecular biology; Pharmaceutical drug discovery and drug development services; Biological research and development services; Scientific condensate-based research in the field of drug discovery and drug development; Providing temporary use of online, non-downloadable computer software using artificial intelligence for machine learning, integrated databases and workflow processes for use in the fields of scientific research and drug discovery
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [009]
Computer & Software Products & Electrical & Scientific Products
Downloadable computer software using artificial intelligence for software development, machine learning, integrated databases and workflow processes in the fields of scientific research and drug discovery
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [005]
Pharmaceutical Products
Pharmaceutical preparations and therapeutic agents for use in the treatment and prevention of neurodegenerative diseases, cancer, metabolic disease, auto-immune diseases, inflammation, infectious disease, prion-based diseases, cardiovascular diseases, women's health in the nature of uterine fibroids and Polycystic Ovary Syndrome (PCOS), renal disease, pulmonary diseases, neurological disease, fibrosis, liver diseases and wound healing; Reagents for medical use; Reagents for clinical use in the nature of clinical medical use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [001]
Chemical Products
Reagents for research use; Reagents for research purposes of drug discovery and development; Reagents for clinical use in the nature of diagnostic reagents for clinical and medical laboratory use
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 97822253
Mark Type
No Service Mark
Attorney Docket Number
No D09062000700
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Design Code(s)
26.03.14 -
Three or more ovals
26.03.21 -
Ovals that are completely or partially shaded
Legal History
| Status Date | Action Taken |
|---|---|
| 02th Dec 2024 | SOU TEAS EXTENSION RECEIVED |
| 04th Jun 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 09th Apr 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 09th Apr 2024 | PUBLISHED FOR OPPOSITION |
| 20th Mar 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 04th Mar 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 26th Feb 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| 26th Feb 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| 26th Feb 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| 27th Nov 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |